German pharma and life sciences major Merck KGaA (MRK: DE) says it expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
“Along with a growing consumer demand, Latin America sees a rise in the need for healthcare products and a trend towards consumer goods making daily life more convenient,” said Uta Kemmerich-Keil, chief executive and president of Merck’s Consumer Health business, at the Financial Times Latin America Healthcare & Life Sciences Summit, held on September 29 in Miami, USA. “Our business is well positioned to anticipating the region’s rapidly changing demographics and responding to consumers’ healthcare needs,” she added.
Latin America playing growth engine role
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze